SRSF2 and cancer: Mutations in spliceosome genes, such as SF3B1, SRSF2 and U2AF1, are prevalent in cancer where they influence alternative splicing110 and miRNA expression.111 Likewise, mutations in these genes may influence circRNA biogenesis but evidence is still lacking.